Butterfly Needles Market Insights & Opportunities 2034

Coverage: Butterfly Needles Market covers analysis By Application (Blood Transfusion, Venipuncture, IV Rehydration, Delivery of Medications); End User (Clinics, Blood Banks); and Geography

Historic Data: 2021-2024   |   Base Year: 2025   |   Forecast Period: 2026-2034
  • Report Date : Mar 2026
  • Report Code : TIPRE00023931
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150
Butterfly Needles Market Insights & Opportunities 2034
Report Date: Mar 2026   |   Report Code: TIPRE00023931
Buy Now
Page Updated: Jan 2026

The Butterfly Needles Market size is expected to reach US$ 500.63 million by 2034 from US$ 244.83 million in 2025. The market is anticipated to register a CAGR of 8.27% during 2026–2034.

Butterfly Needles Market Analysis

The butterfly needles market forecast indicates steady and significant growth, driven by the escalating global prevalence of chronic diseases, increasing demand for patient-safe and highly efficient methods for blood collection and infusion, and widespread adoption across diverse clinical settings. Market expansion is being substantially facilitated by continuous technological advancements in winged infusion set design, with a core focus on reducing patient discomfort and minimizing the occupational risk of needlestick injuries for healthcare workers. Strategic mergers, robust R&D investments, and streamlined regulatory approvals for next-generation safety-engineered devices are key factors enhancing the market's competitive structure and accelerating adoption rates worldwide.

Butterfly Needles Market Overview

Butterfly needles, formally known as winged infusion sets, are specialized venipuncture devices essential for a wide range of medical procedures, including diagnostic blood collection, blood component transfusion, and precise delivery of intravenous fluids and medications. These devices are highly preferred over traditional needles due to their flexible tubing and stabilizing wings, which afford clinicians superior control during insertion, minimizing the risk of vein collapse or trauma, and significantly improving the overall patient experience, particularly for pediatric and geriatric patients. The market landscape is characterized by robust investments in research and development aimed at introducing advanced safety features, supporting continuous regulatory streamlining, and facilitating growing application not only in acute care hospitals and specialized clinics but also in high-volume blood donation centers and the expanding home healthcare sector globally.

Customizee This Report To Suit Your Requirement

Get FREE CUSTOMIZATION

Butterfly Needles Market: Strategic Insights

butterfly-needles-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Butterfly Needles Market Drivers and Opportunities

Market Drivers:

  • Rising Global Burden of Chronic Diseases: The increasing incidence of non-communicable diseases, such as diabetes, cancer, and cardiovascular conditions, necessitates frequent, often long-term, diagnostic blood sampling and intravenous therapy. This sustained and growing need for repeated, controlled venipuncture procedures drives the core demand for minimally invasive devices like butterfly needles.
  • Increasing Demand for Safe and Efficient Blood Collection Methods: Healthcare systems globally are prioritizing clinical supplies that improve workflow efficiency while simultaneously minimizing biological hazards. Safety-engineered butterfly needles meet this critical demand by providing reliable access points and dramatically reducing the occupational risk of needlestick injuries for phlebotomists, nurses, and other clinical personnel.
  • Technological Advancements in Needle Design for Enhanced Patient Comfort: Ongoing innovation is heavily focused on ultra-thin gauge needles, improved wing ergonomics, and specialized coatings. These particular design changes are important in reducing insertion pain, sustaining the adoption rate for advanced winged sets, and ensuring compliance with patient-centric care models.

Market Opportunities:

  • Expansion in Emerging Markets with Improving Healthcare Infrastructure: Regions across Asia-Pacific (APAC) and South and Central America (SCA) are rapidly expanding their hospital networks and modernizing blood bank facilities. This infrastructural growth, combined with rising healthcare expenditure, creates substantial untapped potential for manufacturers to establish distribution channels for advanced infusion sets.
  • Development of Innovative Safety-Engineered Butterfly Needles: Stringent global regulatory emphasis on preventing accidental needlestick injuries creates a persistent and lucrative opportunity for developing and commercializing automated retraction and shielding mechanisms integrated directly into the winged set design. These innovative solutions often command a premium and drive market penetration in safety-conscious regulatory environments.
  • Strategic Partnerships for Global Distribution and Product Innovation: Collaborative agreements between major device manufacturers and strong regional distributors offer a rapid pathway to scale market presence. Furthermore, strategic alliances with clinical bodies can accelerate R&D efforts to integrate smart features, such as flow indicators or digital documentation capabilities, into the devices.

Butterfly Needles Market Report Segmentation Analysis

The butterfly needles market share is analyzed across various segments to provide a clearer understanding of its usage structure, growth potential, and specific end-user trends. Below is the standard segmentation approach used in most industry reports:

By Application:

  • Blood Collection: The largest segment, covering routine diagnostics, disease monitoring, and specialized laboratory sampling across all age groups.
  • Blood Transfusion: Utilizing winged sets for the controlled administration of whole blood or blood components to patients.
  • Venipuncture: The foundational application across all clinical settings requiring peripheral venous access.
  • IV Rehydration: Used for the measured, slow, and safe delivery of intravenous fluids and electrolytes.
  • Delivery of Medications: Employed for administering a variety of injectable drugs, chemotherapy agents, and other liquid therapies.

By End User:

  • Hospitals: Major consumers due to the highest volume of patient turnover, extensive surgical, diagnostic, and emergency procedures.
  • Clinics: A rapidly growing segment driven by the expansion of outpatient procedures and specialist services that require quick, reliable venipuncture access.
  • Blood Banks: Essential for high-volume collection and processing of donor and patient samples, where safety and efficiency are paramount.

 

By Geography:

  • North America
  • Europe
  • Asia Pacific
  • South & Central America
  • Middle East & Africa

Butterfly Needles Market Regional Insights

The regional trends and factors influencing the Butterfly Needles Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Butterfly Needles Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Butterfly Needles Market Report Scope

Report Attribute Details
Market size in 2025 US$ 244.83 Million
Market Size by 2034 US$ 500.63 Million
Global CAGR (2026 - 2034) 8.27%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Application
  • Blood Transfusion
  • Venipuncture
  • IV Rehydration
  • Delivery of Medications
By End User
  • Clinics
  • Blood Banks
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Becton Dickinson and Co. (BD)
  • B. Braun SE
  • Terumo Corp
  • Nipro Corp
  • Cardinal Health Inc
  • Medline Industries Inc
  • SB-Kawasumi Laboratories Inc
  • ICU Medical Inc
  • ISO-MED Inc

Butterfly Needles Market Players Density: Understanding Its Impact on Business Dynamics

The Butterfly Needles Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.


butterfly-needles-market-cagr

  • Get the Butterfly Needles Market top key players overview

Butterfly Needles Market Share Analysis by Geography

The butterfly needles market shows a distinct growth trajectory in each region due to factors such as healthcare technology adoption, existing infrastructure, regulatory environment, and chronic disease prevalence. Below is a summary of market share and trends by region:

  1. North America

    • Market Share: Holds the largest market share due to highly advanced and established healthcare infrastructure, as well as stringent regulatory mandates promoting the immediate adoption of safety-engineered devices.
    • Key Drivers: Widespread acceptance of premium disposable medical products, high public awareness of patient comfort, and the strong presence of key market players driving domestic innovation.
    • Trends: Continuous shift toward using premium safety-winged sets and ongoing efforts to integrate these devices into automated or semi-automated venipuncture systems for enhanced clinical workflow.
  2. Europe

    • Market Share: Commands a significant share, strongly supported by universal public healthcare systems and mandatory regulatory compliance with EU safety directives concerning needlestick injury prevention.
    • Key Drivers: The mandatory adoption of sharp-injury prevention devices in compliance with European Union guidelines and a persistent focus on minimizing healthcare-associated infections.
    • Trends: Increasing demand for highly interoperable butterfly needles that meet specific quality standards required for cross-border health data exchange and unified care delivery models.
  3. Asia-Pacific

    • Market Share: The fastest-growing region globally, driven by rapid healthcare infrastructure development, significant government investments in public health, and the rising prevalence of lifestyle-related chronic conditions.
    • Key Drivers: Government-supported medical device procurement initiatives, a surge in medical tourism, and rapidly increasing patient volumes in urban healthcare centers across countries like China and India.
    • Trends: Mass adoption of high-quality, cost-effective butterfly needles to meet the quickly expanding diagnostic and therapeutic needs of large and diverse populations.
  4. South and Central America (SCA) & Middle East and Africa (MEA)

    • Market Share: Emerging markets with substantial untapped growth potential due to improving economic stability and targeted investments in public health services.
    • Key Drivers: Expansion of private clinics and specialist centers, increased access to modern medical equipment, and focused government initiatives to upgrade blood banking and infusion facilities.
    • Trends: High demand for essential, reliable, and cost-effective winged infusion sets that can support a growing volume of complex and routine clinical procedures.

Butterfly Needles Market Players Density: Understanding Its Impact on Business Dynamics

The butterfly needles market is highly competitive and moderately consolidated, characterized by intense rivalry among a few global leaders and numerous regional specialists. Major vendors such as Becton Dickinson (BD), B. Braun, and Terumo Corporation dominate through extensive global distribution networks and continuous, aggressive product innovation in safety-engineered sets.

This competitive environment pushes vendors to differentiate through:

  • Developing and patenting advanced retraction or self-blunting mechanisms to ensure maximum user safety.
  • Focusing on ultra-fine gauge needles to significantly enhance patient comfort during prolonged infusion or repeated blood collection.
  • Achieving comprehensive regulatory approvals (e.g., FDA, CE mark) swiftly to access diverse international markets.
  • Forming strategic, high-volume supply agreements with large hospital groups and government health ministries.

Major Companies operating in the Butterfly Needles Market are:

  1. Becton Dickinson and Co. (BD)
  2. B. Braun SE
  3. Terumo Corp
  4. Nipro Corp
  5. Cardinal Health Inc
  6. Medline Industries Inc
  7. SB-Kawasumi Laboratories Inc
  8. ICU Medical Inc
  9. ISO-MED Inc

Disclaimer: The companies listed above are not ranked in any particular order.

Butterfly Needles Market News and Recent Developments

Becton Dickinson (BD) offers the BD Vacutainer® Push Button Blood Collection Set, a winged infusion (“butterfly”) needle with push‑button safety retraction, available in 21G, 23G, and 25G sizes. This device has been shown to reduce needlestick injuries by up to 88% compared with traditional wingsets. The company also markets the BD Vacutainer® UltraTouch™ Push Button Blood Collection Set, featuring a 5-bevel PentaPoint™ needle design to minimize insertion pain and improve blood flow. Clinical feedback indicated that 56% of pediatric patients experienced no pain, while the device demonstrated 32% lower penetration force and faster fill times compared with conventional needles.

Butterfly Needles Market Report Coverage and Deliverables

The "Butterfly Needles Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

  • Butterfly Needles Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Butterfly Needles Market trends, as well as market dynamics such as drivers, restraints, and key opportunities
  • Detailed PEST and SWOT analysis
  • Butterfly Needles Market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
  • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments in the Butterfly Needles Market
  • Detailed company profiles

Frequently Asked Questions

The market is expected to reach US$ 500.63 million by 2034, growing from US$ 244.83 million in 2025 at a CAGR of 8.27%.

Key drivers include the rising global burden of chronic diseases, increasing demand for safe and efficient blood collection methods, and advancements in safety-engineered needle designs.

The Asia-Pacific region is set to expand the fastest due to rapid healthcare infrastructure development, increasing patient volumes, and government-backed medical device investments.

Blood collection remains the largest segment, supported by high diagnostic testing volumes across hospitals, clinics, and laboratories.

Leading companies include BD, B. Braun, Terumo, Nipro, Cardinal Health, Medline Industries, SB-Kawasumi, ICU Medical, and ISO-MED.
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Our Clients
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
Chat with us
DUNS Logo
87-673-9708
ISO Certified Logo
ISO 9001:2015
GDPR
CCPA